DISHMAN CARBO AMCIS LTD vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of DISHMAN CARBO AMCIS LTD (DCAL) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads DCAL vs SUNPHARMA on 11 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.46 times its book value", "Company has delivered good profit growth of 20.9% CAGR over last 5 years"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 8.93% over past five years.", "Company has a low return on equity of -0.40% over last 3 years.", "Company might be capitalizing the interest cost"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.